Managed Healthcare Executive recently surveyed readers and gathered your predictions for the industry's dramatically changing future
Overall, readers are more pessimistic about the future than in State of the Industry surveys of the past, but much of the pessimism stems from uncertainty. Even though PPACA was signed into law in March, the secretary of Health and Human Services has hundreds of decisions to carry out that will require years of groundwork and far-reaching collaborative efforts with the private sector. For many logistical points, healthcare leaders must simply wait and see. However, once guidance for each PPACA measure is issued, implementation becomes a sudden race against the clock.
Nearly 650 readers completed the 2011 State of the Industry survey via an electronic invitation, including health plans, providers, consultants, administrative firms, pharmacy benefit managers, disease management companies and employers.
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen